Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Prognostic Biomarkers by fMRI of Acceptance and Commitment Therapy in Suicidal Behavior Disorder

NCT02936700 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT02936700
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02936700 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Prognostic Biomarkers by fMRI of Acceptance and Commitment Therapy in Suicidal Behavior Disorder
Lead sponsor
University Hospital, Montpellier
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2015
Completion date
March 5, 2017
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

actual suicidal behavior disorder